Oncolytic Virotherapy

被引：57
|
作者：
Sze, Daniel Y. [1 ]
Reid, Tony R. [3 ]
Rose, Steven C. [2 ]
机构：
[1] Stanford Univ, Sch Med, Div Intervent Radiol, Stanford Canc Ctr, Stanford, CA 94305 USA
[2] Univ Calif San Diego, Div Intervent Radiol, San Diego, CA 92103 USA
[3] Univ Calif San Diego, Moores Canc Ctr, Div Med Oncol, La Jolla, CA 92093 USA
来源：
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY | 2013年 / 24卷 / 08期
关键词：
PHASE-I TRIAL; CLINICAL-TRIAL; REPLICATION-COMPETENT; ADENOVIRUS ONYX-015; VIRUS NV1020; I/II TRIAL; CANCER; INJECTION; THERAPY; JX-594;
D O I：
10.1016/j.jvir.2013.05.040
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Oncolytic Virotherapy is an emerging technology that uses engineered viruses to treat malignancies. Viruses can be designed with biological specificity to infect Cancerous cells preferentially, and to replicate in these cells exclusively. Malignant cells may be killed directly by overwhelming viral infection and lysis, which releases additional viral particles, to infect neighboring cells and distant metastases. Viral infections may also activate the immune system,, unmask stealthy tumor antigens, and aid the immune system to recognize and attack neoplasms. Delivery of live virus particles is potentially complex, and may require the expertise of the interventional community.
引用
收藏
页码：1115 / 1122
页数：8
相关论文
共 50 条
  • [31] Oncolytic virotherapy of glioblastoma: an overview
    Rommelaere, Jean
    HUMAN GENE THERAPY, 2011, 22 (06) : A7 - A7
  • [32] Oncolytic Virotherapy Reaches Adolescence
    Hammill, Adrienne M.
    Conner, Joseph
    Cripe, Timothy P.
    PEDIATRIC BLOOD & CANCER, 2010, 55 (07) : 1253 - 1263
  • [33] Oncolytic virotherapy for urological cancers
    Delwar, Zahid
    Zhang, Kaixin
    Rennie, Paul S.
    Jia, William
    NATURE REVIEWS UROLOGY, 2016, 13 (06) : 334 - 352
  • [34] Delivery and Biosafety of Oncolytic Virotherapy
    Li, Lizhi
    Liu, Shixin
    Han, Duoduo
    Tang, Bin
    Ma, Jian
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [35] Oncolytic virotherapy of gynecologic malignancies
    Hartkopf, Andreas D.
    Fehm, Tanja
    Wallwiener, Diethelm
    Lauer, Ulrich
    GYNECOLOGIC ONCOLOGY, 2011, 120 (02) : 302 - 310
  • [36] Syncytia Formation in Oncolytic Virotherapy
    Burton, Chase
    Bartee, Eric
    MOLECULAR THERAPY-ONCOLYTICS, 2019, 15 : 131 - 139
  • [37] Recent patents in oncolytic virotherapy
    Ahmad, Tauqeer
    Venkataraman, Srividhya
    AbouHaidar, Mounir
    Hefferon, Kathleen L.
    Recent Patents on Biotechnology, 2015, 9 (02) : 79 - 85
  • [38] Oncolytic virotherapy for urological cancers
    Zahid Delwar
    Kaixin Zhang
    Paul S. Rennie
    William Jia
    Nature Reviews Urology, 2016, 13 : 334 - 352
  • [39] Oncolytic Virotherapy for Malignant Gliomas
    Forsyth, Peter A.
    Abate-Daga, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (14) : 1440 - +
  • [40] Oncolytic virotherapy: Challenges and solutions
    Goradel, Nasser Hashemi
    Baker, Alexander T.
    Arashkia, Arash
    Ebrahimi, Nasim
    Ghorghanlu, Sajjad
    Negahdari, Babak
    CURRENT PROBLEMS IN CANCER, 2021, 45 (01)
12345